Markets:

Overview

News

Currencies

International

Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

216.77 +0.66 (+0.31%)

Official Closing Price Updated: 7:00 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

What Does Charles River's Debt Look Like? ↗

January 12, 2023

Over the past three months, shares of Charles River Inc. (NYSE:CRL) increased by 16.70%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its...

Via Benzinga

Charles River Establishes eXpDNA™ Plasmid Manufacturing Platform to Expedite DNA Programs

January 12, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories to Present at J.P. Morgan Healthcare Conference

January 09, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks ↗

January 06, 2023

Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too.

Via Investor's Business Daily

Why Charles River Laboratories Stock Is Jumping Today ↗

November 02, 2022

Investors liked the company's Q3 update.

Via The Motley Fool

Expert Ratings for Charles River ↗

September 30, 2022

Within the last quarter, Charles River (NYSE:CRL) has observed the following analyst ratings:

Via Benzinga

Charles River Laboratories Adds Craig B. Thompson, M.D. to Board of Directors

December 06, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Launches Endosafe Nexus 200, Emphasizes Critical Importance of Smart Automation for Endotoxin Detection

December 01, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Opens Contract Vivarium Space in Chicago, Enhancing Access to AAALAC-Accredited, Turnkey Research Program

November 28, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

5 Analysts Have This to Say About Charles River ↗

September 30, 2022

Within the last quarter, Charles River (NYSE:CRL) has observed the following analyst ratings:

Via Benzinga

Where Charles River Stands With Analysts ↗

September 30, 2022

Charles River (NYSE:CRL) has observed the following analyst ratings within the last quarter:

Via Benzinga

Charles River Laboratories to Present at November Investor Conferences

November 14, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Demonstrates Excellence in Advanced Modalities at Neuroscience 2022

November 10, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Announces Cell Therapy Manufacturing Capacity Expansion, Reinforcing Commitment to CDMO Clients

November 07, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Analyst Ratings for Charles River ↗

November 03, 2022

Over the past 3 months, 5 analysts have published their opinion on Charles River (NYSE:CRL) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday ↗

November 03, 2022

Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results.

Via Benzinga

United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday ↗

November 03, 2022

U.S. stocks closed lower on Wednesday, with the Dow Jones dropping more than 500 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session ↗

November 02, 2022

Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results.

Via Benzinga

Charles River: Q3 Earnings Insights ↗

November 02, 2022

Charles River (NYSE:CRL) reported its Q3 earnings results on Wednesday, November 2, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Charles River beat estimated...

Via Benzinga

Charles River Laboratories Announces Third-Quarter 2022 Results

November 02, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Medpace Earnings Are 'Almost Unbelievable'; MEDP Stock Flies ↗

October 25, 2022

Medpace earnings soared in Q3 as weakness in contract awards turned to strength, sending MEDP stock surging.

Via Investor's Business Daily

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 18, 2022

Gainers

Via Benzinga

Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership

October 18, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Schedules Third-Quarter 2022 Earnings Release and Conference Call

October 11, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Launches nAAVigation Vector Platform to Accelerate Gene Therapy Programs

October 10, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session ↗

September 30, 2022

Gainers

Via Benzinga

Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday ↗

October 03, 2022

Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.

Via Benzinga

Micron, Charles River Laboratories And Some Other Big Stocks Moving Higher On Friday ↗

September 30, 2022

U.S. stocks traded slightly higher, with the Nasdaq Composite gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2022 ↗

September 30, 2022

Upgrades

Via Benzinga

'Right Now, You've Still Got To Avoid The Stock,' Jim Cramer Says About This Aerospace Company ↗

September 30, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Sherwin-Williams Co (NYSE: SHW) might go lower as the PE (price-to-earnings) multiple is still "way too high" on the stock.

Via Benzinga

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.